Narayana Hrudayalaya (NSE:NH) Q2 FY27: Revenue Up 73% YoY, PAT ₹301.2 Crore
NiveshIQ
NSE: NH · Healthcare
Narayana Hrudayalaya Ltd.
₹1,834.20▲ ₹114.00 (+6.63%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on NH. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Narayana Hrudayalaya Ltd.
Narayana Hrudayalaya Limited (NH) operates a diversified healthcare portfolio across India, the UK, and the Cayman Islands, delivering services in oncology, cardiac surgery, neurology, and a broad spectrum of specialty care. In FY27 Q2, the company reported revenue of ₹10,312 Cr and net income of ₹864 Cr, reflecting a 12% YoY revenue growth and a 15% increase in operating margin. Recent developments include the issuance of CCPS worth ₹8,999,999,550 to NH Investment & Securities Co., which strengthens capital structure and supports expansion plans. NH’s competitive edge stems from its integrated care model, high-volume surgical capabilities, and a growing network of specialty centers that command premium pricing. Analysts project a 78% upside in intrinsic value, with a target price of ₹2,23
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹5,018 Cr +10.91% | ₹5,483 Cr +9.26% | ₹7,896 Cr +44.01% |
| EBITDA Margin | 22.96% | 23.28% | 20.47% |
| Net Profit | ₹789.26 Cr +30.19% | ₹790.15 Cr +0.11% | ₹805.60 Cr +1.95% |
| EPS | ₹38.86 | ₹38.90 | ₹39.67 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Narayana Hrudayalaya reports consolidated operating revenue of ₹28,440 Mn for Q2 FY27
Narayana Hrudayalaya NSE:NH Q2 FY27 Results Investor Update
🔒
+ 3 more stories about Narayana Hrudayalaya Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q2FY27 results: revenue ₹2, 844 Cr, PAT ₹301 Cr, EPS ₹14.82, EBITDA margin 19.5%. Growth context: revenue YoY +73.0%, PAT YoY +16.5%, revenue QoQ +6.0%, PAT QoQ +45.3%.
Management highlighted order wins, a robust deal pipeline, backlog build, geographic expansion, and international growth...
FY26 (last completed FY): revenue ₹7, 896 Cr, PAT ₹806 Cr, EBITDA margin 20.5%, EPS ₹39.67. Year-on-year: revenue YoY +4...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Healthcare stocks
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for NH
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track NH alongside your other holdings
Unlock full NH research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Narayana Hrudayalaya Ltd.?
NiveshIQ detects active intelligence signals for Narayana Hrudayalaya Ltd. (NH) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Narayana Hrudayalaya Ltd.?
Narayana Hrudayalaya Ltd. operates in the Healthcare sector with a market capitalisation of ₹3,928,356.9L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.